L-lysinamide - CAS号查询

Pralmorelin;
D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide;
(2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-amino-3-naphthalen-2-yl-propanoyl]amino]propanoyl]amino]-3-(1

C42H50N8O5

详情

供应商

22572-04-9

丝赖促皮质18肽

a1-18-Corticotropin,1-D-serine-17-L-lysine-18-L-lysinamide- (8CI,9CI);
1-D-Ser-17,18-Lys-b-corticotropin-(1-18)-octadecapeptideamide;
1-D-Serine-17-L-lysine-18-L-lysine-b1-18-corticotropinamide;
1-D-Serine-17-lysine-18-lysinamide-a1-18-ACTH;
1-D-Seryl-17-lysyl-18-lysinamide-a1-18-ACTH;
Ba 41795;
C 41795Ba;
Codactide;
D-Ser-1-lys-17,18-b1-18-corticotropin-lys-18-amide;
D-Serine1-lysine17,18-b1-18-corticotropin-lysine18-amide;
[1-D-Serine, 17,18-dilysine]-b-corticotrophin-(1-18)-octadecapeptide-amide

a1-16-Corticotropin,16-L-lysinamide- (8CI,9CI);
16-L-lysinamide-a1-16-corticotropin;
16-L-lysinamide-a1-16-corticotropinamide;
ACTH1-16-NH2;
b1-16-Corticotropin amide

Carbamic acid,[(5S)-5,6-diamino-6-oxohexyl]-, 1,1-dimethylethyl ester, monohydrochloride(9CI);
Carbamicacid, (5,6-diamino-6-oxohexyl)-, 1,1-dimethylethyl ester, monohydrochloride,(S)-;
N(e)-Boc-L-lysinamide hydrochloride

H-甘酰氨-天冬酰氨-天冬酰氨-天冬酰氨-天冬酰氨-赖酰氨-β-萘胺

L-lysinamide, glycyl-L-a-aspartyl-L-a-aspartyl-L-a-aspartyl-L-a-aspartyl-N-2-naphthalenyl-;
3-8-Trypsinogen(human pancreas isoenzyme 2 activation peptide), 3-glycine-8-(N-2-naphthalenyl-L-lysinamide)-(9CI)

L-lysinamide, L-a-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-,(1®6)-lactam;
1,4,7,10,13,18-Hexaazacyclotricosane,cyclic peptide deriv.

L-lysinamide,D-valyl-L-leucyl-N-(4-nitrophenyl)-;
D-Val-Leu-Lys-p-nitroanilide;
D-Valyl-L-leucyl-L-lysine 4-nitroanilide;
D-Valyl-L-leucyl-L-lysine p-nitroanilide;
D-Valyl-L-leucyl-L-lysyl p-nitroanilide;
D-Valyl-leucyl-lysine-p-nitroanilide;
H-D-Val-Leu-Lys-p-nitroanilide

L-lysinamide,L-histidyl-D-tryptophyl-L-arginyl-L-tryptophyl-D-phenylalanyl-;
5: PN:JP2009035525 PAGE: 3 unclaimed sequence;
U 77123E

L-lysinamide,glycyl-L-histidyl-N-[2-[4-(methoxycarbonyl)[2,4'-bithiazol]-2'-yl]ethyl]- (9CI);
N-(glycyl-histidyl-lysyl)-2-(4’’-methoxycarbonyl-2’’,4’-bithiazol-2’-yl)ethylamine

L-lysinamide,L-alanyl-L-phenylalanyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)- (9CI);
AFK-AMC;
H-ALA-PHE-LYS-AMC;
H-ALA-PHE-LYS-AMC TFA;
H-ALA-PHE-LYS-AMC TRIFLUOROACETATE SALT;
L-ALA-PHE-LYS-7-AMIDO-4-METHYLCOUMARIN SALT;
ala-phe-lys 7-amido-4-methylcoumarin

L-lysinamide,6-carboxy-N6-[N-(1-oxododecyl)-L-alanyl-D-g-glutamyl]-, (6S)- (9CI);
L-lysinamide,6-carboxy-N6-[N-[N-(1-oxododecyl)-L-alanyl]-D-g-glutamyl]-, (S)-;
RP 56142;
Tabilautide

L-lysinamide,N-(3-carboxy-1-oxopropyl)-L-alanyl-L-alanyl-L-prolyl-N-(4-nitrophenyl)-;
1: PN:WO02070688 PAGE: 20 claimed protein;
Succinyl-Ala-Ala-Pro-Lys-p-nitroanilide

L-lysinamide,L-alanyl-L-alanyl-L-alanyl-L-seryl-L-phenylalanyl-L-lysyl-L-alanyl-L-lysyl-(9CI);
alanyl-alanyl-alanyl-seryl-phenylalanyl-lysyl-alanyl-lysyL-lysinamide